
Orbie Pharm
欧博方
Orbie Pharm
Biotech/Healthcare
Oubofang is a leading Chinese pet health company engaged in R&D, manufacturing, and sales. Its self-developed Class 1.1 new veterinary drug for pets was approved by the Ministry of Agriculture, making it the first new pet drug approved since the founding of the PRC.
Latest round: Strategic (2018)
Source: ChinaBulls — chinabulls.com
Last updated 2018-11-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.